Insmed (INSM)
(Real Time Quote from BATS)
$74.61 USD
-0.36 (-0.48%)
Updated Sep 20, 2024 03:02 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Insmed (INSM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$83.06 | $102.00 | $54.00 | 10.79% |
Price Target
Based on short-term price targets offered by 16 analysts, the average price target for Insmed comes to $83.06. The forecasts range from a low of $54.00 to a high of $102.00. The average price target represents an increase of 10.79% from the last closing price of $74.97.
Analyst Price Targets (16)
Broker Rating
Insmed currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on 17 recommendations.
Of the 17 recommendations deriving the current ABR, 17 are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 17 | 17 | 17 | 17 | 17 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/18/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/9/2024 | Cantor Fitzgerald & Co | Jennifer Kim | Strong Buy | Strong Buy |
8/29/2024 | H.C. Wainwright & Co. | Andrew S Fein | Strong Buy | Strong Buy |
8/15/2024 | Mizuho SecuritiesUSA | Graig Suvannavejh | Strong Buy | Strong Buy |
8/12/2024 | Truist Securities | Nicole Germino | Strong Buy | Strong Buy |
8/9/2024 | Cowen & Co. | Ritu S Baral | Strong Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/21/2024 | Evercore Partners | Liisa A Bayko | Strong Buy | Strong Buy |
6/4/2024 | Guggenheim Securities | Vamil Divan | Strong Buy | Strong Buy |
5/31/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/30/2024 | SVB Securities | Joseph P Schwartz | Strong Buy | Strong Buy |
5/29/2024 | UBS | Trung Huynh | Strong Buy | Strong Buy |
5/15/2024 | Goldman Sachs | Andrea Tan | Strong Buy | Strong Buy |
4/1/2024 | Wells Fargo Securities | Tiago Fauth | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 17 |
Average Target Price | $83.06 |
LT Growth Rate | 26.60% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 85 of 253 |
Current Quarter EPS Est: | -1.19 |
INSM FAQs
Insmed, Inc. (INSM) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms.
The average price target for Insmed, Inc. (INSM) is $83.06. The current on short-term price targets is based on 9 reports.
The forecasts for Insmed, Inc. (INSM) range from a low of $54 to a high of $102. The average price target represents a increase of $10.79 from the last closing price of $74.97.
The current UPSIDE for Insmed, Inc. (INSM) is 10.79%
Based on short-term price targets offered by 16 analysts, the average price target for Insmed comes to $83.06. The forecasts range from a low of $54.00 to a high of $102.00. The average price target represents an increase of 10.79% from the last closing price of $74.97.